Construct Tuning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Construct Tuning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Construct Tuning Today - Breaking & Trending Today

Neoleukin Therapeutics : Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome - Form 8-K -December 19, 2023 at 07:34 am EST

Published: December 19, 2023

Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome Two pediatric patients with Rett...

Source: marketscreener.com

Related Topics:

Baylor College Of MedicineUnited StatesNew YorkMelissa ForstBernhard SuterRachel McminnDavid RosenDrug AdministrationNeoleukin Therapeutics IncSecurities ExchangeExchange CommissionNeurogene IncNeurogene Doses First PatientsFemale Pediatric PatientsExpression AttenuationConstruct TuningOrphan Drug DesignationRare Pediatric Disease DesignationFast Track DesignationPrincipal InvestigatorAssociate ProfessorBaylor CollegeTexas ChildrenGood Manufacturing PracticesDaniel Curry